After finishing at $12.05 in the prior trading day, Alx Oncology Holdings Inc (NASDAQ: ALXO) closed at $13.38, up 11.04%. In other words, the price has increased by $+1.33 from its previous closing price. On the day, 587137 shares were traded.
Ratios:
Our goal is to gain a better understanding of ALXO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.24 and its Current Ratio is at 5.24. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 08, 2024, Downgraded its rating to Hold and sets its target price to $14 from $10 previously.
On December 08, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $18.
Jefferies Downgraded its Buy to Hold on December 22, 2021, whereas the target price for the stock was revised from $65 to $25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 04 ’24 when Pons Jaume sold 20,000 shares for $11.15 per share. The transaction valued at 223,036 led to the insider holds 628,359 shares of the business.
Lettmann Jason bought 4,400 shares of ALXO for $49,771 on Mar 14 ’24. The CHIEF EXECUTIVE OFFICER now owns 171,620 shares after completing the transaction at $11.31 per share. On Jan 04 ’24, another insider, Pinto Shelly, who serves as the SVP, Finance and CAO of the company, sold 2,717 shares for $13.60 each. As a result, the insider received 36,957 and left with 78,591 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 670.78M and an Enterprise Value of 505.25M.
Stock Price History:
Over the past 52 weeks, ALXO has reached a high of $17.42, while it has fallen to a 52-week low of $3.94. The 50-Day Moving Average of the stock is 13.66, while the 200-Day Moving Average is calculated to be 9.66.
Shares Statistics:
The stock has traded on average 395.34K shares per day over the past 3-months and 600.8k shares per day over the last 10 days, according to various share statistics. A total of 49.95M shares are outstanding, with a floating share count of 27.36M. Insiders hold about 45.44% of the company’s shares, while institutions hold 57.80% stake in the company. Shares short for ALXO as of Mar 15, 2024 were 2.91M with a Short Ratio of 7.89, compared to 3.53M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.81% and a Short% of Float of 11.86%.
Earnings Estimates
Its stock is currently analyzed by 6 different market analysts. On average, analysts expect EPS of -$0.84 for the current quarter, with a high estimate of -$0.64 and a low estimate of -$0.99, while EPS last year was -$0.74. The consensus estimate for the next quarter is -$0.84, with high estimates of -$0.71 and low estimates of -$1.
Analysts are recommending an EPS of between -$2.8 and -$4 for the fiscal current year, implying an average EPS of -$3.27. EPS for the following year is -$2.96, with 5 analysts recommending between -$2.16 and -$4.3.
